Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, shared on X:
“2 days of updates in thoracic oncology at ALKLinic+ in Taipei together with group of international experts in the field.
Thanks Pfizer for organising this very well balanced annual educational event.”
You might be interested in:
Phase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD
